Avita Medical (ASX:AVH) published clinical results that showed two patients with complex full-thickness hand wounds treated with its collagen-based dermal matrix, Cohealyx, achieved autograft readiness within days, rather than the weeks seen with existing dermal matrices, according to a Thursday statement by the company.
One patient showed a well-vascularized wound bed by day five and received an autograft by day seven, while the second patient achieved robust revascularization by day 10 and underwent grafting on day 13, the company said.
Revascularization is the restoration of blood supply to a tissue or organ.
Both showed strong wound bed vascularization and successful graft take, the company added.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。